-
Product Insights
FG Empreendimentos/ Havan – Balneario Camboriu Triumph Tower – Santa Catarina
Equip yourself with the essential tools needed to make informed and profitable decisions with our FG Empreendimentos/ Havan - Balneario Camboriu Triumph Tower - Santa Catarina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
FG Aledo Dev/ FWFW – Morningstar Mixed-Use Development – Texas
Equip yourself with the essential tools needed to make informed and profitable decisions with our FG Aledo Dev/ FWFW - Morningstar Mixed-Use Development - Texas report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
FG Empreendimentos – Balneario Camboriu Horizon Residence Residential Complex – Santa Catarina
Equip yourself with the essential tools needed to make informed and profitable decisions with our FG Empreendimentos - Balneario Camboriu Horizon Residence Residential Complex - Santa Catarina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
FibroGen Inc – Company Profile
FibroGen Inc (FibroGen) is a biopharmaceutical company that discovers, and develops medicines for the treatment of anemia, cancer, and fibrotic disease. Its approved product includes roxadustat for the treatment of treatment of anemia associated with chronic kidney disease, in both dialysis-dependent (DD) and non-dialysis-dependent (NDD) patients. Its pipeline product includes pamrevlumab (FG-3019) for the treatment of idiopathic pulmonary fibrosis (IPF) and duchenne muscular dystrophy (DMD). The company has operations in the US, Hong Kong, Finland, Cayman Islands and China. FibroGen...
Add to Basket -
Product Insights
Net Present Value Model: Pamrevlumab
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Pamrevlumab Drug Details Pamrevlumab (FG-3019) is...
-
Product Insights
Net Present Value Model: Roxadustat
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Roxadustat Drug Details Roxadustat (Ai Ruizhuo,...
-
Product Insights
Net Present Value Model: Evrenzo
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Evrenzo Drug Details Roxadustat (Ai Ruizhuo,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – pamrevlumab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pamrevlumab Drug Details Pamrevlumab (FG-3019) is under development for the treatment of idiopathic pulmonary...
-
Company Profile
Kyushu Financial Group Inc – Company Profile
Kyushu Financial Group Inc (Kyushu Financial) is a holding company, which offers banking and other financial solutions to individual and corporate customers through its subsidiaries, including The Higo Bank, The Kagoshima Bank, and Kyushu FG Securities. Its portfolio of offerings comprises accounts and deposit services such as general accounts, ordinary deposits, savings deposits, current accounts, certificate of deposits, and foreign currency deposits; lending solutions, which include loans for education, card, reform, and housing; investment products such as government bonds and...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – roxadustat
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry roxadustat Drug Details Roxadustat (Ai Ruizhuo, Evrenzo) is an anti-anemic agent. It is formulated...